These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 7567933)
1. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas. Terada T; Hoso M; Nakanuma Y Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933 [TBL] [Abstract][Full Text] [Related]
2. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis]. Tátrai P Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466 [TBL] [Abstract][Full Text] [Related]
3. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hytiroglou P; Theise ND; Schwartz M; Mor E; Miller C; Thung SN Hepatology; 1995 Mar; 21(3):703-8. PubMed ID: 7875667 [TBL] [Abstract][Full Text] [Related]
4. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases. Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450 [TBL] [Abstract][Full Text] [Related]
5. [Precancerous stages of hepatocellular carcinoma]. Tanikawa K Gan To Kagaku Ryoho; 1995 Dec; 22(14):2055-61. PubMed ID: 8607615 [TBL] [Abstract][Full Text] [Related]
6. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules. Kwon Y; Lee SK; Kim JS; Ro JY; Yu E Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757 [TBL] [Abstract][Full Text] [Related]
7. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study. Kaji K; Terada T; Nakanuma Y Am J Gastroenterol; 1994 Jun; 89(6):903-8. PubMed ID: 8198103 [TBL] [Abstract][Full Text] [Related]
8. Histopathological and immunohistochemical analysis of adenomatous hyperplasia and hepatocellular carcinoma: cellularity, thickness of cell cord, and Ki-67 proliferative activity. Than KW; Okayasu I; Akashi T Bull Tokyo Med Dent Univ; 1995 Jun; 42(2):67-81. PubMed ID: 7540960 [TBL] [Abstract][Full Text] [Related]
9. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys. Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor in cirrhotic liver, adenomatous hyperplastic nodule and hepatocellular carcinoma in the human. Nagasue N; Yamanoi A; Kohno H; Kimoto T; Chang Y; Taniura H; Uchida M; Nakamura T Hepatogastroenterology; 1992 Oct; 39(5):455-60. PubMed ID: 1334038 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. Seki S; Sakaguchi H; Kitada T; Tamori A; Takeda T; Kawada N; Habu D; Nakatani K; Nishiguchi S; Shiomi S Clin Cancer Res; 2000 Sep; 6(9):3469-73. PubMed ID: 10999730 [TBL] [Abstract][Full Text] [Related]
12. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry. Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806 [TBL] [Abstract][Full Text] [Related]
14. Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma. Zhao M; Laissue JA; Zimmermann A Histol Histopathol; 1996 Apr; 11(2):323-33. PubMed ID: 8861754 [TBL] [Abstract][Full Text] [Related]
15. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081 [TBL] [Abstract][Full Text] [Related]
16. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma. de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218 [TBL] [Abstract][Full Text] [Related]
17. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'. Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067 [TBL] [Abstract][Full Text] [Related]
18. Hepatic precancerous lesions and small hepatocellular carcinoma. Hytiroglou P; Park YN; Krinsky G; Theise ND Gastroenterol Clin North Am; 2007 Dec; 36(4):867-87, vii. PubMed ID: 17996795 [TBL] [Abstract][Full Text] [Related]
19. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma. Szczepański W Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407 [TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological significance of adenomatous hyperplasia of the liver]. Nakashima O; Kojiro M Nihon Rinsho; 1994 Jan; 52(1):75-9. PubMed ID: 8114314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]